By Ruben Carbonell, Arpan Mukherjee, Jonathan Dordick, and Christopher J. Roberts
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published technology roadmaps addressing needs and gaps in three key product areas: gene therapy, antibody-dug conjugates, and vaccines. The roadmaps were developed with the collaborative input of industry, academic, and government experts. This article highlights technology opportunities for gene therapy manufacturing.
The drive toward sustainable, “green” processes in biopharmaceuticals seems like a daunting challenge. However, the right tools can integrate “green” practices into every aspect of the development workflow. This case study explores how one BIOVIA customer rolled out BIOVIA Workbook across its process chemistry division to around 1,000 scientists and the “green” benefits the group saw.